Faculty profile

Simon Turcotte

Back to faculty

Chercheur régulierDépartement de chirurgieUniversité de Montréal

Simon Turcotte

Chercheur régulier

Département de chirurgie

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

This is a research or leadership role; ask the department whether it includes supervision.
18 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 FRQS), most recently in 2021.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,672

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Multi-omics fusion network for prediction of early recurrence in colorectal liver metastases.
NPJ precision oncology · 2026
Multi-Institutional CT Scan-Based Radiomics for Predicting Tumor PD-L1 Expression in Patients with Advanced and Limited Non-Small Cell Lung Cancer.
Cancers · 2026
Oncological outcomes associated with primary-first, liver-first and synchronous resection strategies in synchronous colorectal liver metastases.
Surgical oncology · 2026

All 36 publications

Latest funding

Creating a biomimetic 3D engineered model of the liver metastatic niche
SSHRC · 2023 · Co-investigator
$250,000
Targeting the extracellular adenosine pathway in pancreatic and liver cancers
CIHR · 2021 · Co-investigator
$765,000
Chercheurs-boursiers cliniciens
FRQS · 2021 · Principal investigator
$75,765

All 5 grants and awards

36 publications.

Multi-omics fusion network for prediction of early recurrence in colorectal liver metastases.

Saber R, Carneiro M, Montagnon E, Tang A, Turcotte S, Kadoury S

NPJ precision oncology20262 citationsOpen Access

DOI: 10.1038/s41698-025-01264-2 PMID: 41513955

Multi-Institutional CT Scan-Based Radiomics for Predicting Tumor PD-L1 Expression in Patients with Advanced and Limited Non-Small Cell Lung Cancer.

Saber R, Tonneau M, Salko O, Liberman M, Malo J, Elkrief A, Turcotte S, Bouchard N, Joubert P, Kadoury S, Routy B

Cancers2026Open Access

DOI: 10.3390/cancers18040552 PMID: 41749806

Oncological outcomes associated with primary-first, liver-first and synchronous resection strategies in synchronous colorectal liver metastases.

Haddad Y, Beauchamp A, Hénault D, Rong Z, Dagenais M, Plasse M, Roy A, Vandenbroucke-Menu F, Létourneau R, Lapointe R, Turcotte S, Simoneau E

Surgical oncology2026

DOI: 10.1016/j.suronc.2026.102537 PMID: 42636613

Peripheral Blood as the Sole Source for Cancer Neoantigen and Reactive T-Cell Discovery.

Garcia-Garijo A, Creus-González I, Levy PL, Moreno-Cárdenas AB, Prieto-Fernández E, Lozano-Rabella M, Fajardo CA, Pujol-Borrell R, Marín-Bayo A, Kusnick J, Gonzalez J, Brujas C, Gartner JJ, Yuste-Estevanez A, Calahorro AM, Louhamane A, Fernandez J, Sanz-Pamplona R, Watkins TBK, Galvao V, Munoz-Couselo E, Ros J, Élez E, Oliveira M, Saura Manich C, Brana I, Oaknin A, Alemany R, Tabernero J, Perez-Lopez R, Turcotte S, Frankell AM, Garralda E, Toledo RA, Gros A

Cancer discovery2026

DOI: 10.1158/2159-8290.cd-25-1779 PMID: 42806482

Semi-supervised ViT knowledge distillation network with style transfer normalization for colorectal liver metastases survival prediction.

Elforaici MEA, Montagnon E, Romero FP, Le WT, Azzi F, Trudel D, Nguyen B, Turcotte S, Tang A, Kadoury S

Medical image analysis202517 citations

DOI: 10.1016/j.media.2024.103346 PMID: 39423564

Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3).

Attieh S, Angka L, Lafontaine C, Mitchell C, Carignan J, Ilkow C, Turcotte S, Goodwin R, Auer RC, Loiselle CG

Current oncology (Toronto, Ont.)20252 citationsOpen Access

DOI: 10.3390/curroncol32080436 PMID: 40862805

Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.

Delisle JS, Fournier D, Santerre K, Rochette S, Zawati MH, Dumont-Lagacé M, Turcotte S, Guertin JR, Vermette P, Tremblay JP, Parisotto M, Beauséjour C, Gélinas JF, Petropoulos L, Kekre N, Michaud S, Dieudé M

Frontiers in medicine20252 citationsOpen Access

DOI: 10.3389/fmed.2025.1581058 PMID: 40529124

Prediction of acute kidney injury in the immediate postoperative period following liver resection: a retrospective cohort study.

Abou Jamous J, Ferreira Guerra S, Haida Z, Amzallag É, Girard M, Turcotte S, Carrier FM

Canadian journal of anaesthesia = Journal canadien d'anesthesie2025

DOI: 10.1007/s12630-025-02996-2 PMID: 40659919

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.

Frontiers in medicine2025Open Access

DOI: 10.3389/fmed.2025.1710876 PMID: 41179894

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Coukos G, Donia M, Gastman BR, Goff SL, Gros A, Harari A, Hernandez S, Ito F, Maker AV, Mullinax JE, Murthy P, Pai SI, Prabhakaran S, Restifo NP, Silver NL, Marincola Smith P, Turcotte S, Wagner PL, Yang JC, Lotze MT

Journal for immunotherapy of cancer2025

DOI: 10.1136/jitc-2025-013420 PMID: 41320228

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Simon Turcotte

Research

Latest papers

Latest funding

Multi-omics fusion network for prediction of early recurrence in colorectal liver metastases.

Multi-Institutional CT Scan-Based Radiomics for Predicting Tumor PD-L1 Expression in Patients with Advanced and Limited Non-Small Cell Lung Cancer.

Oncological outcomes associated with primary-first, liver-first and synchronous resection strategies in synchronous colorectal liver metastases.

Peripheral Blood as the Sole Source for Cancer Neoantigen and Reactive T-Cell Discovery.

Semi-supervised ViT knowledge distillation network with style transfer normalization for colorectal liver metastases survival prediction.

Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3).

Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Qu&#xe9;bec, Canada.

Prediction of acute kidney injury in the immediate postoperative period following liver resection: a retrospective cohort study.

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Qu&#xe9;bec, Canada.

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Creating a biomimetic 3D engineered model of the liver metastatic niche

Targeting the extracellular adenosine pathway in pancreatic and liver cancers

Chercheurs-boursiers cliniciens

Injectable thermosensitive hydrogel as delivery vehicle of lymphocytes for cancer immunotherapy

Chercheurs-boursiers cliniciens

Frequent collaborators

An Tang

Samuel Kadoury

John Stagg

Jacques-P. Tremblay

Natasha Kekre

Christian Beausejour

Dominique Trudel

Bertrand Routy

Mélanie Dieudé

François Carrier

Ma'n Zawati

Arielle Elkrief

Jean-Sébastien Delisle

Patrick Vermette

Réjean Lapointe

Bich Nguyen

Christopher Pal

Elizabeth Arslanian

Kim Dubé

Simon Lapierre

Rachel Goodwin

Rebecca Auer

Martin Girard

Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.